Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CodeLab Capital AS (CODE.OL)
NOK3.12
-0.38 (-10.86%)
NO OSL Healthcare Medical - Healthcare Information Services
Address
Postboks 339 213
Oslo, NO
Oslo, NO
CEO
Anton Lorenz Bondesen
Website
codelabcapital.com
IPO
2023-05-15
ISIN NO0013483503
Description
CodeLab Capital AS offers cloud-based software services to healthcare professionals and their partners, with operations spanning Norway and global markets. The company's primary activity involves creating and continually enhancing the PatientSky cloud platform and its supporting technologies, all dedicated to improving patient care. Established in 2014, the firm is headquartered in Oslo, Norway, and was previously recognized as PatientSky Group AS.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
NOK3.12
-0.38 (-10.86%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
31.5K
Beta
0.68
Float Shares
14.38M
Free Float %
99.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +8.53% | -3.45% | +16.18% | +12.90% | +16.67% | -3.11% | +493.22% | -62.26% | -69.57% | -69.57% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
3.12
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-4.83
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+4,819.1% ★ Q2'25: -93.9% (vs Q2'24)
-
EPS growth Medical - Healthcare Information Services: +43.1%-150.0% Q2'25: +87.9% (vs Q2'24)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-117.8% Q2'25: -241,341.0% (vs Q2'24)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-126.9% Q2'25: -168,504.8% (vs Q2'24)
-
ROIC Medical - Healthcare Information Services: +5.2%-88.3% Q2'25: -71.7% (vs Q2'24)
-
Share dilution Medical - Healthcare Information Services: -0.1%-95.8% ★ Q2'25: +26.4% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.28× Q2'25: -0.27× (vs Q2'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|
| Revenue |
139.78M
est: 140.00M (-0.2%)
|
208.63M
est: 210.00M (-0.7%)
|
194.64M
est: 194.80M (-0.1%)
|
59.17M
est: 51.40M (+15.1%)
|
249.4K
est: 102.97M (-99.8%)
|
12.27M
est: 62.00M (-80.2%)
|
| EBITDA |
31.58M
est: 1.55M (+1,942.7%)
|
-10.30M
est: 2.32M (-544.2%)
|
-23.62M
est: 2.15M (-1,197.8%)
|
61.49M
est: 567.6K (+10,733.5%)
|
-144.79M
est: -23.53M (-515.5%)
|
-11.92M
est: -14.17M (+15.9%)
|
| EBIT |
-22.03M
est: -46.19M (+52.3%)
|
-93.76M
est: -69.28M (-35.3%)
|
-144.50M
est: -64.27M (-124.8%)
|
41.33M
est: -16.96M (+343.7%)
|
-149.07M
est: -51.32M (-190.5%)
|
-15.56M
est: -30.90M (+49.6%)
|
| Net Income |
-23.46M
est: 683.59M (-103.4%)
|
-91.81M
est: -683.59M (+86.6%)
|
-154.59M
est: -8.99B (+98.3%)
|
30.04M
est: -3.22B (+100.9%)
|
-150.88M
est: -62.97M (-139.6%)
|
-15.90M
est: 57.82M (-127.5%)
|
| SGA |
14.96M
est: 567.72M (-97.4%)
|
46.65M
est: 851.58M (-94.5%)
|
88.24M
est: 789.95M (-88.8%)
|
9.81M
est: 208.43M (-95.3%)
|
4.82M
est: 415.33M (-98.8%)
|
—
est: 250.09M (-100.0%)
|
| EPS |
-0.12
est: 2.00 (-106.0%)
|
-0.46
est: -2.00 (+77.0%)
|
-0.79
est: -26.30 (+97.0%)
|
7.55
est: -9.42 (+180.2%)
|
-0.44
est: -4.36 (+89.9%)
|
-1.10
est: 4.00 (-127.5%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-36.61M
OE per share TTM
-0.11
Owner's Yield
-90.45%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
10.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-536.6K
Shares Outstanding
14.45M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andreas Kruger | Co-founder & Chief Technology Officer of PaaS | — | male |
| Anton Lorenz Bondesen | Chief Executive Officer & Director | — | male |
| Christoffer Mathiesen | Chief Financial Officer | — | male |
| Egil Natvik Noen | Chief Commercial Officer | — | male |
| Kjell Magne Solli | Managing Director of Norway | — | male |
| Sesame Turquoise Baker | Chief People & Culture Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CODE.OL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
